Negative-sense single-stranded RNA virus

Last updated

Negative ssRNA Virus
Ebola Virus TEM PHIL 1832 lores.jpg
Ebola Virus
Virus classification
Group:
Group V ((−)ssRNA)
Order, Family, and Genus

A negative-sense single-stranded RNA virus (or (-)ssRNA virus) is a virus that uses negative sense, single-stranded RNA as its genetic material. Single stranded RNA viruses are classified as positive or negative depending on the sense or polarity of the RNA. The negative viral RNA is complementary to the mRNA and must be converted to a positive RNA by RNA polymerase before translation. Therefore, the purified RNA of a negative sense virus is not infectious by itself, as it needs to be converted to a positive sense RNA for replication. These viruses belong to Group V on the Baltimore classification. [1]

Contents

In addition, negative-sense single-stranded RNA viruses have complex genomic sequences, cell cycles, and replication habits that use various protein complexes to arrange in specific conformations and carry out necessary processes for survival and reproduction of their genomic sequences. The complexity of negative-sense single-stranded RNA viruses carries into its ability to suppress the innate immune response of the cells it infects and the construction of a capsid, which is unique to the varying classifications of negative-sense single-stranded RNA viruses.

Replication

Negative sense ssRNA viruses need RNA polymerase to form a positive sense RNA. The positive-sense RNA acts as a viral mRNA, which is translated into proteins for the production of new virion materials. With the newly formed virions, more negative sense RNA molecules are produced.

In more details, replication of the virion consists of the following steps: [2] [3] [4]

  1. A virion enters the host cell and releases its negative RNA into the cytoplasm.
  2. The virus uses its own RNA replicase, also known as RNA-dependent RNA polymerase (RdRp), to form positive RNA template strands through complementary base pairing.
  3. The positive RNA acts as mRNA, which is translated into structural capsomere proteins and viral RdRp by the host's ribosomes.
  4. A replicative complex is formed with RdRp: The positive strands can either function as mRNA to produce more proteins or as template to make more negative RNA strands.
  5. New viral capsids are assembled with the capsomere proteins. The negative RNA strands combine with capsids and viral RdRp to form new negative RNA virions.
  6. After assembly and maturation of nucleocapsid, the new virions exit the cell by budding or lysing through cell membrane to further infect other cells.

The genome size of a negative RNA virus is between 10kb to 30kb. Two genome subgroups can be distinguished, nonsegmented and segmented, and are described as such:

Taxonomy

One phylum, two subphyla, six classes, eight orders and twenty one families are currently recognised in this group. [5] A number of unassigned species and genera are yet to be classified. [6] Outside the all encompassing Negarnaviricota phylum there is only Deltavirus genus.

Host range

Viruses of the families Arenaviridae, Orthomyxoviridae, Paramyxoviridae, and Pneumoviridae are able to infect vertebrates. Viruses of the families Bunyaviridae and Rhabdoviridae are able to infect vertebrates, arthropods, and plants. Viruses of the genus Tenuivirus only infect plants. A few viruses known to infect humans include Marburg virus, Ebola, measles, mumps, rabies, and influenza.

Genome

The genome for negative-stranded RNA virus (NSV) consists of one to several single-stranded RNAs, which are assembled into complexes. [9] These complexes function as templates for the transcription and replication of the NSV genome by RNA polymerase. The NSV genome has been observed as being either segmented and nonsegmented. [9] The segmented genome can be divided up into anywhere between 2-8 RNA molecules. [9] A distinctive feature of the NSV genome is its highly structured organization. Multiple monomers of either the ribonucleoprotein (RNP) complexes or nucleocapsids associate with the RNA to create these organized complexes. [9] Nonsegmented RNA follows a sequential pattern of gene expression. [9] With segmented RNA, each individual segment is contained in a distinct RNP complex. [9] These complexes function independently for transcription and replication related processes. [9]

NSV ribonucleoproteins (RNPs) generally adopt a helical conformation. [9] For nonsegmented NSVs, these conformations are typically linear in fashion, and are relatively rigid. [10] [11] Segmented NSVs are present in a more flexible, circular conformation. [12] This results from non-covalent RNA-RNA interactions between the 5’- and 3’-termini of the RNA segments. [13] Regarding the helical character of NSV RNPs, the main determinant of this conformation is the NP/N protein. [9] The structure of virion full-length RNPs are typically presented as a left-handed, double-helical arrangement of two NP strands that are opposite in polarity. [9] Recombinant RNPs have a different structure, generally consisting of a right-handed helix. [14] Nevertheless, wild type RNPs isolated from virus present left-handed helix [15]

Catalytic activity related to RNA synthesis is associated with a very large protein, termed the L protein. This is a multi-enzymatic polypeptide that is responsible for multiple tasks. These activities span multiple domains, including mRNA synthesis/modification and the formation of ribonucleoproteins. [16] [17] Through phylogenetic analysis, it was determined that NSV RNA polymerases share a common ancestor with other RNA polymerases from various origins. [9] This is further supported by various L proteins displaying highly conserved sequence blocks that are in series, yet separated by variable regions. [18]

When discussing the NSV RNP, the NP/N protein is considered to be the most abundant element of the ribonucleoprotein. [9] These elements are what provide the basis for the RNPs helical conformation. [9] NP/N proteins are also vital for the transcription and replication of full-length RNA templates. [9] The proper function of NP/N proteins rely on their capacity to oligomerize. This defines the ability of NP/N proteins to complex together to form larger structural elements. The oligomerization mechanism is unique between the nonsegmented NSV genome (nsNSV) and segmented NSV genome (sNSV). [9] For nsNSVs, interactions occur between the protein monomers, while the stabilization of this complex occurs through inter-monomeric contact involving N-terminal and/or C-terminal protein extensions. [11] [19] [20] This contributes to the viral RNP helical structure. [10] [11] [21] Oligomerization for sNSVs has been shown to be similar to this for some Bunyaviridae, but it may also take place much more flexibly, defined by their ability to form much smaller oligomers. [22] [9] These include, but are not limited to, dimers, trimers, tetramers, long helices, and more complex structures. [9]

NSV Life Cycle and Replication

Negative-strand RNA viruses (NSV) can be classified into 21 distinct families. The families consisting of nonsegmented genomes include Rhabdo-, Paramyxo-, Filo- and Borna-. Orthomyxo-, Bunya-, Arenaviridae- contain genomes of six to eight, three, or two negative-sense RNA segments, respectively. [23] Many highly prevalent human pathogens such as the respiratory syncytial virus (RSV), parainfluenza viruses, influenza viruses, Ebola virus, Marburg virus are included within the NSV. The life cycle of NSV has a number of steps. The virus first infects the host cell by binding to the host cell receptor through a viral surface glycoprotein. [24] The fusion of the glycoprotein viral membrane with the plasma membrane of the host cell in an acidic environment allows for the release of viral ribonucleoprotein (RNP) complexes into the cytoplasm. Most NSV replicate in the cytoplasm of infected cells. Newly synthesized RNP complexes are assembled with viral structural proteins at the plasma membrane or at membranes of the Golgi apparatus. [23] This is all followed by the release of the newly synthesized viruses.

In regards to the replication and transcription of non-segmented NSV, the genes of these NSV are made up of three regulatory regions: a gene end signal, an intergenic region, and a gene start signal. [23] [25] One example of gene end signals are in a specific virus called the vesicular stomatitis virus (VSV) contains gene end signals that are highly conservative. The intergenic region is highly variable and consists of conserved dinucleotide, trinucleotide, or regions of up to 143 nucleotides. [25] The various lengths of the intergenic regions correlate with transcriptional attenuation, however diverse intergenic regions do not alter the gene expression. The gene start signals are highly specific as the first three nucleotides are critical for the gene expression. [23] [25] [26]

Molecular Mechanisms of Innate Antiviral Immune Inhibition

A cell’s innate immune response is the first line of defense for finding viral infections. The innate immune response triggers the production of type I interferons (IFN) and pro-inflammatory cytokines. [27] [28] However, non-segmented negative sense RNA viruses (NNSV) have developed multifunctional proteins that can diffuse this innate response pathway to avoid antiviral functions within the cell. [28] This mainly occurs through the NNSV's proteins interacting with other cellular proteins involved in the type I interferon signaling pathway. [27] Due to the expansive nature of the immune pathway, NNSVs have a variety of areas throughout the signaling cascade that can be targeted for interruption of the production of type I interferons or pro-inflammatory cytokines. [29] Such areas include inhibiting the induction of the IFN pathway or inhibiting the response from the IFN signaling cascade.

NNSV-Mediated Inhibition of IFN Induction

NNSVs target several induction pathway areas, as outlined in the image, to avoid detection within the cell, or even inhibit that specific area of the signaling cascade. One such example of NNSVs avoiding cellular detection arises with mutations, which sequester the pathogen-associated molecular pathways. [27] [30] By creating a mutation within the nucleotide sequence, specifically ones important for binding double stranded DNA or other proteins, the virus is able to go undetected by cell, avoid activation of the cellular antiviral response, and evade the immune response.

NNSVs can also bind to cellular receptors throughout the pro-inflammatory cytokine pathway to inhibit the immune response. [27] By carrying accessory proteins that directly bind to pattern recognition receptors, the virus can use its accessory proteins to induce conformational changes throughout other immune response proteins and inhibit cellular responses. [29] Generally, the pattern recognition receptors detect infection-associated molecules commonly associated with viruses, but some viruses carry accessory proteins that reconfigure the protein to inhibit its function and block the rest of the signaling cascade that would produce an immune response.

Other areas of inhibition of induction apply similar concepts of binding to cellular proteins and inhibiting their function throughout the immune cascade. [27] [28] These include binding to proteins involved in dephosphorylation pathways and blocking DNA binding transcription factors. In each case, the accessory proteins coded for in the nucleotide sequence inhibit a critical function of other innate cellular proteins, disrupting the signaling cascade for producing type I interferons and pro-inflammatory cytokines.

NNSV-Mediated Inhibition of IFN Response

Another way that NSVs avoid the host immune response is to encode for proteins that target the JAK/STAT pathway or the nuclear transports mechanisms for transcription factors. Each of these are a portion of the IFN pathway described previously in the immune system’s innate response to viral infection.

JAK/STAT pathway JAK-STAT Pathway overview as related to NNSVs.png
JAK/STAT pathway

For the JAK/STAT pathway depicted in the image, a critical reaction for inducing the pathway is the proper phosphorylation of the TYK2 and JAK1 proteins. [27] Upon phosphorylation, the rest of the STAT pathway will begin and lead to the production of antiviral genes. [31] NNSVs have the capability to synthesize proteins that target the phosphorylation step of the pathway. By preventing the phosphorylation of TYK2 and JAK1, they stop the IFNα/β pathway and bring the antiviral immune response to a halt. [32] Similarly, viruses can also synthesize proteins that prevent the phosphorylation of STAT1 a little further along the signaling cascade. This process halts the IFNα/β pathway, just like preventing phosphorylation of TYK2 and JAK1.

Further down the IFNα/β pathway, STAT1 and STAT2 are transported across the nuclear membrane, as depicted in the image. [27] [32] They accordingly bind to the DNA sequence and behave as transcription factors- affecting the level of gene production throughout the cell. In normal cellular function, this pathway will behave normally in response to viral infection, leading to the production of antiviral genes and the induction of an immune response. [27] However, NNSVs have developed the capability to generate complexes that target the protein responsible for translocating STAT1 across the nuclear membrane. By binding to and inhibiting this function, STAT1 is never able to bind to the DNA and properly regulate the production of antiviral genes. [31] [32] This pathway of inhibiting the IFN response helps the NNSV go undetected within the cell and avoid certain immune response pathways.

Ubiquitination

Another important process used throughout many cellular processes is ubiquitination—which is outlined in the image below. Many cells use this to locate and identify viruses, and to restrict the viral infection. [33] NNSVs however have developed a pathway to synthesize proteins that target the ubiquitin pathway along many of the signaling cascades descriptive of the IFN response. More specifically, the NNSVs are capable of reprogramming the host cell’s ubiquitination pathway in a way that leads to the degradation of host cell mechanism that would otherwise silence a viral infection. [34]

Ubiquitination Pathway Ubiquitination Pathway as related to NNSVs.png
Ubiquitination Pathway

Common Mechanism for RNA Encapsidation by NSVs

Like all viruses, negative-sense RNA viruses (NSVs) contain a protein capsid that encapsulates the genomic material. The nucleocapsid of NSVs is assembled with a single nucleocapsid protein, and the viral RNA. Each NSV nucleocapsid is packaged inside a lipid envelope, but the appearance of the nucleocapsid differs from virus to virus. [35] For example, in rhabdoviruses, the nucleocapsid assumes a bullet shape, [21] while in paramyxoviruses, the nucleocapsid is filamentous or herringbone-like. [36] However, when the nucleocapsids are released from the virion, they all appear like a coil. [35]

So far, the atomic structures of nucleocapsid-like-particles (NLP) have been elucidated for three NSV families: Rhabdoviridae, Paramyxoviridae, and Bunyaviridae. One important element of NSVs is that the capsid protein (N) is first synthesized as a monomeric protein (N0). N0 is a capsid protein that assembles a capsid to accommodate any RNA sequence. N0 is kept monomeric in different ways depending on which family of NSVs a virus falls into. For instance, rhabdoviruses keep the N0 monomeric by forming a complex with the phosphoprotein (P). [21] It has been found that both the N- and C terminal regions of P bind to the capsid protein. Essentially, the P binding occupies the site required for N0 oligomerization. Other viruses, such as bunyaviruses, simply sequester the N terminus by N itself. Nonetheless, it is essential for N to be monomeric for the NSV to be competent in encapsidating viral RNA. [21]

In terms of the structure of the nucleocapsid, the N protein will eventually oligomerize to encapsidate the single-stranded RNA. In some NSVs the N subunits are oriented in a parallel orientation, and the ssRNA is sequestered in the center. In most NSVs, the nucleocapsid appears to be a random coil, and the symmetry is linear. [37] Because the N subunits are oriented in a parallel fashion, the cross-molecular interactions among the subunits stabilize the nucleocapsid and are critical for capsid formation. The linear interactions along the encapsidated single-stranded RNA are actually a unique feature to NSVs. [21] X-ray crystal structures of N proteins and EM micrographs of RNP complexes from a number of Bunyaviridae (a Family of segmented NSVs that includes the Bunyamwera virus and the Schmallenberg virus) show that in these viruses the nucleocapsid adopts a helical arrangement where the N proteins form a head-to-tail chain by linking to each other via a flexible N-terminal arm. The resulting chain forms tight coils with four N proteins per turn that holds the circular ssRNA of these viruses on the inside of the coils and extend to form large circular filaments. [22]

Structure of a Nucleocaspid Structure of a nucleocaspid.png
Structure of a Nucleocaspid

The process of encapsidation is a concomitant process with viral replication, likely at the site of the viral RNA replication process. [38] Another unique feature of NSVs is that the sequestered bases are stacked to form a motif similar to half of the A-form double helix of RNA. The stacking arrangement allows for maximized packaging of the RNA in the capsid. [21] The base stacking may actually contribute to the overall stability of the nucleocapsid, and is dependent on the RNA sequence (i.e. poly(rA) is the most stable). [39] An interesting finding is that specific sequences in the sequestered RNA genome may regulate viral functions. For translational termination, there is a U7 track at the end of each coding region, causing this to be the least stable region. This therefore promotes dissociation of the transcription complex. [21] A unique aspect of NSVs is the conserved (3H+5H) motif, which has been identified to constitute the RNA cavity through secondary structur e elements of the N protein. [40]

Lastly, a main distinction between NSVs from other viruses is that the nucleocapsid actually serves as the template for viral RNA synthesis. During synthesis, the nucleocapsid undergoes a conformational change to release the RNA template. After transcription is complete, the RNA is repositioned in the cavity, and the nucleocapsid is restored. [21]

See also

Related Research Articles

<i>Parvoviridae</i> Family of viruses

The Parvoviridae are a family of small, rugged, genetically-compact DNA viruses, known collectively as parvoviruses. There are currently >75 species in the family, divided among 13 genera and two subfamilies. Members of this family infect a wide array of animal hosts and have been divided into two subfamilies, which infect either vertebrates or invertebrates (Densovirinae).

<i>Paramyxoviridae</i> viruses of the Paramyxoviridae family, responsible for a number of human and animal diseases

Paramyxoviridae is a family of viruses in the order Mononegavirales. Vertebrates serve as natural hosts; no known plants serve as vectors. Currently, 72 species are placed in this family, divided among 14 genera. Diseases associated with this negative-sense, single-stranded RNA virus family include measles, mumps, and respiratory tract infections.

<i>Hepadnaviridae</i>

Hepadnaviridae is a family of viruses. Humans, apes, and birds serve as natural hosts. There are currently over 12 species in this family, divided among 5 genera. Its best-known member is hepatitis B virus. Diseases associated with this family include: liver infections, such as hepatitis, hepatocellular carcinomas, and cirrhosis.

Picornavirus family of viruses

A picornavirus is a virus belonging to the family Picornaviridae, a family of viruses in the order Picornavirales. Vertebrates, including humans, serve as natural hosts. Picornaviruses are nonenveloped viruses that represent a large family of small, cytoplasmic, plus-strand RNA (~7.5kb) viruses with a 30-nm icosahedral capsid. Its genome does not have a lipid membrane. Picornaviruses are found in mammals and birds. There are currently 80 species in this family, divided among 35 genera. Notable examples are Enterovirus, Aphthovirus, Cardiovirus, and Hepatovirus genera. The viruses in this family can cause a range of diseases including paralysis, meningitis, hepatitis and poliomyelitis. Picornaviruses are in Baltimore IV class. Their genome single-stranded (+) sense RNA is what functions as mRNA after entry into the cell and all viral mRNA synthesized is of genome polarity. The mRNA encodes RNA dependent RNA polymerase. This polymerase makes complementary minus strands of RNA, then uses them as templates to make more plus strands. So, an overview of the steps in picornavirus replication are in order: attachment, entry, translation, transcription/genome replication, assembly and exit.

<i>Rubella virus</i> species of virus

Rubella virus (RuV) is the pathogenic agent of the disease rubella, and is the main cause of congenital rubella syndrome when infection occurs during the first weeks of pregnancy.

Rabies virus species of virus

Rabies lyssavirus, formerly Rabies virus, is a neurotropic virus that causes rabies in humans and animals. Rabies transmission can occur through the saliva of animals and less commonly through contact with human saliva. Rabies lyssavirus, like many rhabdoviruses, has an extremely wide host range. In the wild it has been found infecting many mammalian species, while in the laboratory it has been found that birds can be infected, as well as cell cultures from mammals, birds, reptiles and insects.

<i>Lassa mammarenavirus</i> Type of viral hemorrhagic fever

Lassa mammarenavirus (LASV) is an arenavirus that causes Lassa hemorrhagic fever, a type of viral hemorrhagic fever (VHF), in humans and other primates. Lassa mammarenavirus is an emerging virus and a select agent, requiring Biosafety Level 4-equivalent containment. It is endemic in West African countries, especially Sierra Leone, the Republic of Guinea, Nigeria, and Liberia, where the annual incidence of infection is between 300,000 and 500,000 cases, resulting in 5,000 deaths per year.

Gammaretrovirus is a genus in the retroviridae family. Example species are the murine leukemia virus and the feline leukemia virus. They cause various sarcomas, leukemias and immune deficiencies in mammals, reptiles and birds.

Nucleoprotein proteins conjugated with nucleic acids

Nucleoproteins are any proteins that are structurally associated with nucleic acids, either DNA or RNA. Typical nucleoproteins include ribosomes, nucleosomes, and viral nucleocapsid proteins.

<i>Alphavirus</i> genus of viruses

Alphavirus is a genus of RNA viruses, the sole genus in the Togaviridae family. Alphaviruses belong to group IV of the Baltimore classification of viruses, with a positive-sense, single-stranded RNA genome. There are 31 alphaviruses, which infect various vertebrates such as humans, rodents, fish, birds, and larger mammals such as horses, as well as invertebrates. Transmission between species and individuals occurs mainly via mosquitoes, making the alphaviruses a member of the collection of arboviruses – or arthropod-borne viruses. Alphavirus particles are enveloped, have a 70 nm diameter, tend to be spherical, and have a 40 nm isometric nucleocapsid.

The genome and proteins of HIV have been the subject of extensive research since the discovery of the virus in 1983. "In the search for the causative agent, it was initially believed that the virus was a form of the Human T-cell leukemia virus (HTLV), which was known at the time to affect the human immune system and cause certain leukemias. However, researchers at the Pasteur Institute in Paris isolated a previously unknown and genetically distinct retrovirus in patients with AIDS which was later named HIV." Each virion comprises a viral envelope and associated matrix enclosing a capsid, which itself encloses two copies of the single-stranded RNA genome and several enzymes. The discovery of the virus itself occurred two years following the report of the first major cases of AIDS-associated illnesses.

Baltimore classification Virus classification system by David Baltimore consisting of 7 groups based on genome type (DNA or RNA), number of strands (single- or double-stranded), sense (positive or negative), and method of replication (through DNA or RNA intermediate)

The Baltimore classification, developed by David Baltimore, is a virus classification system that groups viruses into families, depending on their type of genome and their method of replication.

Dependoparvovirus is a genus in the subfamily Parvovirinae of the virus family Parvoviridae; they are Group II viruses according to the Baltimore classification. Some dependoparvoviruses are also known as adeno-associated viruses because they cannot replicate productively in their host cell without the cell being coinfected by a helper virus such as an adenovirus, a herpesvirus, or a vaccinia virus.

Double-stranded RNA viruses type of virus according to Baltimore

Double-stranded (ds) RNA viruses are a diverse group of viruses that vary widely in host range, genome segment number and virion organization. Members of this group include the rotaviruses, known globally as a common cause of gastroenteritis in young children, and bluetongue virus, an economically important pathogen of cattle and sheep.

Virus Small non-cellular infectious agent that only replicates in cells

A virus is a small infectious agent that replicates only inside the living cells of an organism. Viruses can infect all types of life forms, from animals and plants to microorganisms, including bacteria and archaea.

Cafeteria roenbergensis virus (CroV) is a giant virus that infects the marine bicosoecid flagellate Cafeteria roenbergensis, a member of the microzooplankton community.

<i>Pneumoviridae</i> Family of viruses

Pneumoviridae is a new virus family in the order Mononegavirales. It was created in 2016 by elevating the now dissolved paramyxoviral subfamily Pneumovirinae. Natural hosts include humans, cattle, and rodents. There are currently 5 species in the Pneumoviridae family, divided between 2 genera. Pneumoviruses are pleomorphic, capable of producing spherical and filamentous enveloped virions that vary in size from 150 to 200 nm in diameter. The nucleocapsid consisting of a protein shell and viral nucleic acids has a helical symmetry. Nucleocapsids have a diameter of 13.5 nm and a helical pitch of 6.5 nm. The genome is composed of negative-sense single-stranded RNA that is non-segmented. It is about 15kb in size, and encodes 11 proteins. A unique feature of the genome is the M2 gene, which encodes proteins M2-1 and M2-2. The Pneumoviridae M2-1 protein is distinctive, and no homologue has been found in any other virus families. It functions as a processivity factor for the virus RNA-dependent RNA polymerase, and promotes viral RNA synthesis. Viruses in this family are often associated with respiratory infections, and are transmitted through respiratory secretions.

Positive-sense single-stranded RNA virus Class of viruses in the Baltimore classification

A positive-sense single-stranded RNA virus is a virus that uses positive sense, single-stranded RNA as its genetic material. Single stranded RNA viruses are classified as positive or negative depending on the sense or polarity of the RNA. The positive-sense viral RNA genome can serve as messenger RNA and can be translated into protein in the host cell. Positive-sense ssRNA viruses belong to Group IV in the Baltimore classification. Positive-sense RNA viruses account for a large fraction of known viruses, including many pathogens such as the hepacivirus C, West Nile virus, dengue virus, SARS and MERS coronaviruses, and SARS-CoV-2 as well as less clinically serious pathogens such as the rhinoviruses that cause the common cold.

Feline morbillivirus comes from the family Morbillivirus, specifically influencing wild and domestic cats. The first report of a Feline morbillivirus outbreak occurred in Hong Kong in 2012. Approximately 10% of stray cats in Hong Kong and mainland China were reported to possess the virus at the time with additional infections found in Japan as well. 40% of cats tested in Japan were Fmo-PV positive and exhibited early symptoms of renal failure. While the first cases of Feline morbillivirus were found in China, Hong Kong and Japan, the virus can also be found in Italy, Germany, and the United States. Feline morbillivirus exhibits a substantial amount of genetic diversity, yet cases in Japan and Hong Kong proved to have identical nucleotide sequences. It is also hypothesized that the morbillivirus has high adaptability due to its presence in multiple species. It is often found in dogs, cats, cattle, whales, dolphins, porpoises, and even humans. It likely originated from an ancestral version and underwent viral evolution to adapt to transmission in different species. Other common morbilliviruses include: measles, rinderpest virus, canine distemper virus and peste des petits ruminants virus.

<i>Sepik virus</i> Mosquito transmitted virus endemic to Papua New Guinea

Sepik virus (SEPV) is an arthropod-borne virus (arbovirus) of the genus Flavivirus and family Flaviviridae. Flaviviridae is one of the most well characterized viral families, as it contains many well-known viruses that cause diseases that have become very prevalent in the world, like Chikungunya virus and Dengue virus. The genus Flavivirus is one of the largest viral genuses and encompasses over 50 viral species, including tick and mosquito borne viruses like Yellow fever virus and West Nile virus. Sepik virus is much less well known and has not been as well-classified as other viruses because it has not been known of for very long. Sepik virus was first isolated in 1966 from the mosquito Mansoniaseptempunctata, and it derives its name from the Sepik River area in Papua New Guinea, where it was first found. The geographic range of Sepik virus is limited to Papua New Guinea, due to its isolation.

References

[27] [41] [42] [43] [44]

  1. Baltimore, D (1971). "Expression of animal virus genomes". Bacteriological Reviews. 35 (3): 235–241. doi:10.1128/MMBR.35.3.235-241.1971. PMC   378387 . PMID   4329869.
  2. Samuel, Charles E (2005). "Virus-Host Interaction Minireview Series: Human Immunodeficiency Virus, Hepatitis C Virus, and Influenza Virus". The Journal of Biological Chemistry. 281 (13): 8305–7. doi:10.1074/jbc.R500032200. PMID   16407181.
  3. Hofkin, Bruce (2010). Living in a Microbial World. Garland Science. ISBN   9780815341758.
  4. Rybicki, Ed. "Viral Replication Strategy in Negative-Sense Single-Stranded RNA Viruses". ASM Microbe Library. American Society for Microbiology. Archived from the original on 23 October 2014. Retrieved 14 April 2015.
  5. Cann, Alan (2011). Principles of Molecular Virology. Academic Press. ISBN   978-0-12-384939-7.
  6. Klein, Donald W.; Prescott, Lansing M.; Harley, John (1993). Microbiology. Dubuque, Iowa: Wm. C. Brown. ISBN   978-0-697-01372-9.
  7. "Virus Taxonomy: 2018 Release". International Committee on Taxonomy of Viruses . Retrieved 13 November 2018.
  8. Mihindukulasuriya, K. A.; Nguyen, N. L.; Wu, G.; Huang, H. V.; Travassos da Rosa, A. P.; Popov, V. L.; Tesh, R. B.; Wang, D. (2009). "Nyamanini and Midway viruses define a novel taxon of RNA viruses in the order Mononegavirales". J. Virol. 83 (10): 5109–16. doi:10.1128/JVI.02667-08. PMC   2682064 . PMID   19279111.
  9. 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 Ortín, Juan; Martín-Benito, Jaime (2015). "The RNA synthesis machinery of negative-stranded RNA viruses". Virology. 479–480: 532–544. doi:10.1016/j.virol.2015.03.018. PMID   25824479.
  10. 1 2 Schoehn, Guy; Mavrakis, Manos; Albertini, Aurélie; Wade, Richard; Hoenger, Andreas; Ruigrok, Rob W. H. (28 May 2004). "The 12 Å Structure of Trypsin-treated Measles Virus N–RNA". Journal of Molecular Biology. 339 (2): 301–312. doi:10.1016/j.jmb.2004.03.073. PMID   15136034.
  11. 1 2 3 Tawar, Rajiv G.; Duquerroy, Stéphane; Vonrhein, Clemens; Varela, Paloma F.; Damier-Piolle, Laurence; Castagné, Nathalie; MacLellan, Kirsty; Bedouelle, Hugues; Bricogne, Gérard (27 November 2009). "Crystal Structure of a Nucleocapsid-Like Nucleoprotein-RNA Complex of Respiratory Syncytial Virus". Science. 326 (5957): 1279–1283. Bibcode:2009Sci...326.1279T. doi:10.1126/science.1177634. ISSN   0036-8075. PMID   19965480.
  12. Raymond, Donald D.; Piper, Mary E.; Gerrard, Sonja R.; Smith, Janet L. (29 June 2010). "Structure of the Rift Valley fever virus nucleocapsid protein reveals another architecture for RNA encapsidation". Proceedings of the National Academy of Sciences. 107 (26): 11769–11774. Bibcode:2010PNAS..10711769R. doi:10.1073/pnas.1001760107. ISSN   0027-8424. PMC   2900692 . PMID   20547879.
  13. Hsu, M. T.; Parvin, J. D.; Gupta, S.; Krystal, M.; Palese, P. (1 November 1987). "Genomic RNAs of influenza viruses are held in a circular conformation in virions and in infected cells by a terminal panhandle". Proceedings of the National Academy of Sciences. 84 (22): 8140–8144. Bibcode:1987PNAS...84.8140H. doi:10.1073/pnas.84.22.8140. ISSN   0027-8424. PMC   299494 . PMID   2446318.
  14. Moeller, Arne; Kirchdoerfer, Robert N.; Potter, Clinton S.; Carragher, Bridget; Wilson, Ian A. (21 December 2012). "Organization of the Influenza Virus Replication Machinery". Science. 338 (6114): 1631–1634. Bibcode:2012Sci...338.1631M. doi:10.1126/science.1227270. ISSN   0036-8075. PMC   3578580 . PMID   23180774.
  15. Arranz, Rocío; Coloma, Rocío; Chichón, Francisco Javier; Conesa, Jose Javier; Carrascora, José L.; Valpuesta, José M.; Martín-Benito, Jaime (21 December 2012). "The Structure of Native Influenza Virion Ribonucleoproteins". Science. 338 (6114): 1634–1637. Bibcode:2012Sci...338.1634A. doi:10.1126/science.1228172. PMID   23180776.
  16. Kranzusch, Philip J.; Whelan, Sean P. J. (1 July 2012). "Architecture and regulation of negative-strand viral enzymatic machinery". RNA Biology. 9 (7): 941–948. doi:10.4161/rna.20345. ISSN   1547-6286. PMC   3495737 . PMID   22767259.
  17. Morin, Benjamin; Kranzusch, Philip J; Rahmeh, Amal A; Whelan, Sean PJ (1 April 2013). "The polymerase of negative-stranded RNA viruses". Current Opinion in Virology. Virus structure and function / Emerging viruses. 3 (2): 103–110. doi:10.1016/j.coviro.2013.03.008. PMC   4159711 . PMID   23602472.
  18. Poch, O; Blumberg, BM; Bougueleret, L; Tordo, N (1990). "Sequence Comparison of Five Polymerases (L proteins) of Unsegmented Negative-strand RNA Viruses: Theoretical Assignment of Functional Domains". Journal of General Virology. 71 (5): 1153–62. doi:10.1099/0022-1317-71-5-1153. PMID   2161049.
  19. Albertini, Aurélie A. V.; Wernimont, Amy K.; Muziol, Tadeusz; Ravelli, Raimond B. G.; Clapier, Cedric R.; Schoehn, Guy; Weissenhorn, Winfried; Ruigrok, Rob W. H. (21 July 2006). "Crystal Structure of the Rabies Virus Nucleoprotein-RNA Complex". Science. 313 (5785): 360–363. Bibcode:2006Sci...313..360A. doi:10.1126/science.1125280. ISSN   0036-8075. PMID   16778023.
  20. Green, Todd J.; Zhang, Xin; Wertz, Gail W.; Luo, Ming (21 July 2006). "Structure of the Vesicular Stomatitis Virus Nucleoprotein-RNA Complex". Science. 313 (5785): 357–360. Bibcode:2006Sci...313..357G. doi:10.1126/science.1126953. ISSN   0036-8075. PMID   16778022.
  21. 1 2 3 4 5 6 7 8 Ge, Peng; Tsao, Jun; Schein, Stan; Green, Todd J.; Luo, Ming; Zhou, Z. Hong (5 February 2010). "Cryo-EM Model of the Bullet-Shaped Vesicular Stomatitis Virus". Science. 327 (5966): 689–693. Bibcode:2010Sci...327..689G. doi:10.1126/science.1181766. ISSN   0036-8075. PMC   2892700 . PMID   20133572.
  22. 1 2 Ariza, Antonio; Tanner, Sian J.; Walter, Cheryl T.; Dent, Kyle C.; Shepherd, Dale A.; Wu, Weining; Matthews, Susan V.; Hiscox, Julian A.; Green, Todd J. (1 June 2013). "Nucleocapsid protein structures from orthobunyaviruses reveal insight into ribonucleoprotein architecture and RNA polymerization". Nucleic Acids Research. 41 (11): 5912–5926. doi:10.1093/nar/gkt268. ISSN   0305-1048. PMC   3675483 . PMID   23595147.
  23. 1 2 3 4 "Replication- competent rhabdoviruses with human immunodeficiency virus type 1 coats and green fluorescent protein: entry by a pH-independent pathway". Journal of Virology. 73.
  24. Calain, Philippe; Curran, Joe; Kolakofsky, Daniel; Roux, Laurent (1 November 1992). "Molecular cloning of natural paramyxovirus copy-back defective interfering RNAs and their expression from DNA". Virology. 191 (1): 62–71. doi:10.1016/0042-6822(92)90166-M. PMID   1329337.
  25. 1 2 3 "Sendai Virus and Simian Virus 5 Block Activation of Interferon-Responsive Genes: Importance for Virus Pathogenesis". Journal of Virology. 73.
  26. Enami, M.; Luytjes, W.; Krystal, M.; Palese, P. (1 May 1990). "Introduction of site-specific mutations into the genome of influenza virus". Proceedings of the National Academy of Sciences. 87 (10): 3802–3805. Bibcode:1990PNAS...87.3802E. doi:10.1073/pnas.87.10.3802. ISSN   0027-8424. PMC   53991 . PMID   2339122.
  27. 1 2 3 4 5 6 7 8 9 Chatterjee, S; Basler, CF; Amarasinghe, GK; Leung, DW (28 August 2016). "Molecular Mechanisms of Innate Immune Inhibition by Non-Segmented Negative-Sense RNA Viruses". Journal of Molecular Biology. 428 (17): 3467–82. doi:10.1016/j.jmb.2016.07.017. PMC   5010489 . PMID   27487481.
  28. 1 2 3 Gerlier, Denis; Lyles, Douglas S. (1 September 2011). "Interplay between Innate Immunity and Negative-Strand RNA Viruses: towards a Rational Model". Microbiology and Molecular Biology Reviews. 75 (3): 468–490. doi:10.1128/MMBR.00007-11. ISSN   1092-2172. PMC   3165544 . PMID   21885681.
  29. 1 2 Leung, Daisy W.; Basler, Christopher F.; Amarasinghe, Gaya K. (2012). "Molecular mechanisms of viral inhibitors of RIG-I-like receptors". Trends in Microbiology. 20 (3): 139–146. doi:10.1016/j.tim.2011.12.005. PMC   3299846 . PMID   22325030.
  30. Yan, Nan; Chen, Zhijian J (2012). "Intrinsic antiviral immunity". Nature Immunology. 13 (3): 214–222. doi:10.1038/ni.2229. PMC   3549670 . PMID   22344284.
  31. 1 2 O'Shea, John J.; Schwartz, Daniella M.; Villarino, Alejandro V.; Gadina, Massimo; McInnes, Iain B.; Laurence, Arian (14 January 2015). "The JAK-STAT Pathway: Impact on Human Disease and Therapeutic Intervention". Annual Review of Medicine. 66 (1): 311–328. doi:10.1146/annurev-med-051113-024537. ISSN   0066-4219. PMC   5634336 . PMID   25587654.
  32. 1 2 3 Rawlings, Jason S.; Rosler, Kristin M.; Harrison, Douglas A. (15 March 2004). "The JAK/STAT signaling pathway". Journal of Cell Science. 117 (8): 1281–1283. doi:10.1242/jcs.00963. ISSN   0021-9533. PMID   15020666.
  33. Isaacson, Marisa K.; Ploegh, Hidde L. (2009). "Ubiquitination, Ubiquitin-like Modifiers, and Deubiquitination in Viral Infection". Cell Host & Microbe. 5 (6): 559–570. doi:10.1016/j.chom.2009.05.012. hdl:1721.1/84989. PMID   19527883.
  34. Cadwell, Ken; Coscoy, Laurent (1 July 2005). "Ubiquitination on nonlysine residues by a viral E3 ubiquitin ligase". Science. 309 (5731): 127–130. Bibcode:2005Sci...309..127C. doi:10.1126/science.1110340. ISSN   1095-9203. PMID   15994556.
  35. 1 2 Neumann, Gabriele; Whitt, Michael A.; Kawaoka, Yoshihiro (1 November 2002). "A decade after the generation of a negative-sense RNA virus from cloned cDNA - what have we learned?". The Journal of General Virology. 83 (Pt 11): 2635–2662. doi:10.1099/0022-1317-83-11-2635. ISSN   0022-1317. PMID   12388800.
  36. Loney, Colin; Mottet-Osman, Geneviève; Roux, Laurent; Bhella, David (15 August 2009). "Paramyxovirus Ultrastructure and Genome Packaging: Cryo-Electron Tomography of Sendai Virus". Journal of Virology. 83 (16): 8191–8197. doi:10.1128/JVI.00693-09. ISSN   0022-538X. PMC   2715783 . PMID   19493999.
  37. Ruigrok, Rob WH; Crépin, Thibaut; Kolakofsky, Dan (2011). "Nucleoproteins and nucleocapsids of negative-strand RNA viruses". Current Opinion in Microbiology. 14 (4): 504–510. doi:10.1016/j.mib.2011.07.011. PMID   21824806.
  38. Green, Todd J.; Luo, Ming (14 July 2009). "Structure of the vesicular stomatitis virus nucleocapsid in complex with the nucleocapsid-binding domain of the small polymerase cofactor, P". Proceedings of the National Academy of Sciences. 106 (28): 11713–11718. Bibcode:2009PNAS..10611713G. doi:10.1073/pnas.0903228106. ISSN   0027-8424. PMC   2710649 . PMID   19571006.
  39. Green, Todd J.; Rowse, Michael; Tsao, Jun; Kang, Jungsoon; Ge, Peng; Zhou, Z. Hong; Luo, Ming (15 March 2011). "Access to RNA Encapsidated in the Nucleocapsid of Vesicular Stomatitis Virus". Journal of Virology. 85 (6): 2714–2722. doi:10.1128/JVI.01927-10. ISSN   0022-538X. PMC   3067934 . PMID   21177817.
  40. Luo, Ming; Green, Todd J.; Zhang, Xin; Tsao, Jun; Qiu, Shihong (1 January 2007). "Structural comparisons of the nucleoprotein from three negative strand RNA virus families". Virology Journal. 4: 72. doi:10.1186/1743-422X-4-72. ISSN   1743-422X. PMC   2031895 . PMID   17623082.
  41. Green, TJ; Cox, R; Tsao, J; Rowse, M; Qiu, S; Luo, M (April 2014). "Common mechanism for RNA encapsidation by negative-strand RNA viruses". Journal of Virology. 88 (7): 3766–75. doi:10.1128/jvi.03483-13. PMC   3993539 . PMID   24429372.
  42. Ortín, J; Martín-Benito, J (May 2015). "The RNA synthesis machinery of negative-stranded RNA viruses". Virology. 479–480: 532–44. doi:10.1016/j.virol.2015.03.018. PMID   25824479.
  43. Neumann, G; Whitt, MA; Kawaoka, Y (November 2002). "A decade after the generation of a negative-sense RNA virus from cloned cDNA - what have we learned?". The Journal of General Virology. 83 (Pt 11): 2635–62. doi:10.1099/0022-1317-83-11-2635. PMID   12388800.
  44. Viswanathan, K; Früh, K; DeFilippis, V (August 2010). "Viral hijacking of the host ubiquitin system to evade interferon responses". Current Opinion in Microbiology. 13 (4): 517–23. doi:10.1016/j.mib.2010.05.012. PMC   2939720 . PMID   20699190.